12:00 AM
 | 
Apr 10, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Serono Pharmaceutical Research Institute preclinical data

Serono researchers presented data showing that its beta sheet breaker inhibited and dissolved amyloid deposits when injected into the brains of...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >